Invesco’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-340,654
| Closed | -$34.7M | – | 3915 |
|
|
2023
Q2 | $34.7M | Sell |
340,654
-62,902
| -16% | -$6.41M | 0.01% | 1093 |
|
|
2023
Q1 | $36.7M | Buy |
403,556
+313,452
| +348% | +$28.5M | 0.01% | 1084 |
|
|
2022
Q4 | $3.42M | Buy |
90,104
+62,997
| +232% | +$2.39M | ﹤0.01% | 2419 |
|
|
2022
Q3 | $681K | Buy |
27,107
+330
| +1% | +$8.29K | ﹤0.01% | 3062 |
|
|
2022
Q2 | $814K | Sell |
26,777
-29,335
| -52% | -$892K | ﹤0.01% | 3067 |
|
|
2022
Q1 | $1.84M | Sell |
56,112
-2,224,297
| -98% | -$72.9M | ﹤0.01% | 2802 |
|
|
2021
Q4 | $60.1M | Sell |
2,280,409
-1,158,395
| -34% | -$30.5M | 0.01% | 971 |
|
|
2021
Q3 | $346M | Buy |
3,438,804
+629,088
| +22% | +$63.3M | 0.09% | 280 |
|
|
2021
Q2 | $398M | Buy |
2,809,716
+753,356
| +37% | +$107M | 0.1% | 259 |
|
|
2021
Q1 | $205M | Buy |
2,056,360
+276,885
| +16% | +$27.6M | 0.05% | 468 |
|
|
2020
Q4 | $220M | Buy |
1,779,475
+1,216,844
| +216% | +$150M | 0.06% | 390 |
|
|
2020
Q3 | $54.8M | Buy |
562,631
+509,453
| +958% | +$49.6M | 0.02% | 901 |
|
|
2020
Q2 | $8.3M | Buy |
53,178
+51,583
| +3,234% | +$8.05M | ﹤0.01% | 1738 |
|
|
2020
Q1 | $231K | Sell |
1,595
-50,342
| -97% | -$7.29M | ﹤0.01% | 3322 |
|
|
2019
Q4 | $10.6M | Buy |
+51,937
| New | +$10.6M | ﹤0.01% | 1730 |
|
|
2019
Q3 | – | Sell |
-18,750
| Closed | -$1.77M | – | 3687 |
|
|
2019
Q2 | $1.77M | Buy |
18,750
+192
| +1% | +$18.1K | ﹤0.01% | 2748 |
|
|
2019
Q1 | $1.59M | Buy |
18,558
+14,276
| +333% | +$1.22M | ﹤0.01% | 2753 |
|
|
2018
Q4 | $240K | Buy |
+4,282
| New | +$240K | ﹤0.01% | 3486 |
|